Related Experiment Video
Updated: Nov 10, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
11.0K
Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
Mee Young Kim1, Hyunwoo Shin2, Hyong Woo Moon3
1Catholic Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Scientific Reports
|April 2, 2021
Summary
Urinary exosomal microRNAs (miRNAs) show promise as biomarkers for aggressive prostate cancer. miR-532-5p in urine exosomes may predict biochemical recurrence (BCR) in intermediate-risk prostate cancer patients.
Area of Science:
- Urology
- Molecular Biology
- Oncology
Background:
- Urinary exosomal microRNAs (miRNAs) are stable biomarkers for urological cancers.
- miRNAs are implicated in aggressive prostate cancer features like biochemical recurrence (BCR) and metastasis.
Purpose of the Study:
- To identify urinary exosomal miRNAs as prognostic markers for BCR in intermediate-risk prostate cancer.
- To evaluate the potential of specific miRNAs as predictive biomarkers for BCR.
Main Methods:
- Next-generation sequencing profiled miRNA expression in urinary exosomes from intermediate-risk prostate cancer patients (21 non-BCR, 6 BCR).
- Differentially expressed miRNAs were validated using quantitative reverse transcription PCR in an independent cohort (28 non-BCR, 26 BCR).
- Cox regression analyses identified predictive factors for BCR.
Main Results:
- Twenty-one urinary exosomal miRNAs were differentially expressed in BCR patients compared to non-BCR patients.
- Three miRNAs (miR-26a-5p, miR-532-5p, miR-99b-3p) were upregulated in exosomes from BCR patients.
- miR-532-5p was identified as a significant predictive factor for BCR in intermediate-risk prostate cancer.
Conclusions:
- Urinary exosomal miR-532-5p may serve as a potential biomarker for predicting BCR in intermediate-risk prostate cancer.
- BCR is associated with a poor prognosis in these patients.
- Further investigation into the biological functions and mechanisms of miR-532-5p is warranted.

